Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who test positive for hepatitis B (HBsAg-positive) and are currently being seen in departments other than infectious disease or hepatology clinics at one of the three study centres.
The following criteria apply to a specific part of the trial called the PRO sub-study:
- People aged 18 years or older.
- People who have never previously received treatment for hepatitis B virus (HBV) infection.
- People whose hepatitis B meets the treatment criteria set out in the 2022 Chinese Guidelines for the Prevention and Treatment of Chronic Hepatitis B.
- People who are able to understand the study information, are willing to take part, and are able to sign a consent form.
- People who are able to complete questionnaires on their own or with some help.
Who may not be able to join:
- People who test positive for hepatitis B and are already attending regular check-ups at an infectious disease or hepatology clinic.
- People with chronic hepatitis B who are already on a regular antiviral treatment programme.
The following additional criteria apply to the PRO sub-study:
- People who have a history of chronic liver disease other than hepatitis B, such as alcoholic liver disease, autoimmune liver disease, or inherited metabolic liver disease; or who are also infected with hepatitis C (HCV), hepatitis D (HDV), or HIV.
- People who have other serious health conditions that could affect quality of life, such as severe heart or brain disease, uncontrolled mental illness, or cancer.
- People who are pregnant or breastfeeding.
- People who are using or plan to use a medicine called pegylated interferon during the study period.
- People who are unable to attend all required follow-up visits.
- People whom the trial investigator considers unsuitable to participate for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Liang Peng, Third Affiliated Hospital, Sun Yat-Sen University
Phone: +8613533978874
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Referral Rate; Changes in Health-Related Quality of Life assessed by the CHBQOL Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.